In the News!
CEOCFO Magazine Interview with MicroMedicine CEO, Ravi Kapur
“MicroMedicine’s technology provides an automated, precise, and high-performance solution for cell isolation. The math is simple – the more cells isolated from whole blood with high purity, the more target cells available for the downstream clinical diagnostic tests and cell therapy. MicroMedicine alleviates the stress of cell isolation and maximizes the cells of interest.”
– Ravi Kapur, PhD.
Propel technological advances in
Clinical Diagnostics, Cellular Therapy,
and Life Sciences using a highly precise
and automated microfluidic platform
for cellular isolation